Highlights NeoGenomics, Inc.

Equities

NEO

US64049M2098

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
15.22 ^USD	+7.64%		+13.41%	-5.93%

Apr. 18	NeoGenomics, Inc. Announces Senior Leadership Promotions	CI
Apr. 18	NeoGenomics, Inc. Announces Eliminates of Position of Vishal Sikri, President, Advanced Diagnostics	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NeoGenomics Swings to Q4 Adjusted Earnings, Revenue Rises; Issues 2024 Guidance	Feb. 21	MT
NeoGenomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 20	CI
Earnings Flash (NEO) NEOGENOMICS Reports Q4 EPS $0.03, vs. Street Est of $-0.03	Feb. 20	MT
Earnings Flash (NEO) NEOGENOMICS Reports Q4 Revenue $155.6M, vs. Street Est of $152.5M	Feb. 20	MT
NeoGenomics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 20	CI
NeoGenomics, Inc. Provides Earnings Guidance for the Year 2024	Feb. 20	CI
Neogenomics, Inc. and Concertai, Llc Announce Collaboration to Advance Population-Scale, Definitive Hematological Research & Generative Ai Solutions At Ash 2023	Jan. 08	CI
NeoGenomics Shares Fall; Company to Appeal Preliminary Injunction in Natera Copyright Battle	Dec. 28	MT
NeoGenomics to Appeal Preliminary Injunction in Natera Copyright Battle	Dec. 28	MT
Natera Winning RaDaR Preliminary Injunction Bodes Poorly for NeoGenomics, Needham Says	Dec. 28	MT
Natera Wins Preliminary Injunction in Copyright Battle Against NeoGenomics	Dec. 28	MT
NeoGenomics Swings to Breakeven Q3 Adjusted Earnings, Revenue Rises; 2023 Revenue Outlook Lifted	Nov. 07	MT
NeoGenomics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 06	CI
Earnings Flash (NEO) NEOGENOMICS Reports Q3 Revenue $152M	Nov. 06	MT
NeoGenomics, Inc. Revises Earnings Guidance for the Full Year Ending December 31, 2023	Nov. 06	CI
Neogenomics, Inc. Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios	23-10-24	CI
NeoGenomics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08	CI
NeoGenomics Q2 Adjusted Loss Narrows, Net Revenue Rises; Full-Year 2023 Outlook Adjusted	23-08-08	MT
Earnings Flash (NEO) NEOGENOMICS Reports Q2 Revenue $146.9M	23-08-08	MT
NeoGenomics, Inc. Revises Earnings Guidance for the Fiscal Year 2023	23-08-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights NeoGenomics, Inc.

Equities

NEO

US64049M2098

Highlights

Filters